Abstract |
Estrogen has traditionally been the only agent effective for the prevention and treatment of post-menopausal osteoporosis. Estrogen's positive effects are often outweighed by negative ones. Newer agents provide safer alternatives that should increase compliance and improve quality of life.
|
Authors | C A Cefalu, C Fontenot |
Journal | Comprehensive therapy
(Compr Ther)
Vol. 27
Issue 2
Pg. 95-103
( 2001)
ISSN: 0098-8243 [Print] United States |
PMID | 11430265
(Publication Type: Journal Article, Review)
|
Chemical References |
- Diphosphonates
- Selective Estrogen Receptor Modulators
- Progesterone
- Calcitonin
|
Topics |
- Calcitonin
(therapeutic use)
- Diphosphonates
(therapeutic use)
- Drug Therapy, Combination
- Estrogen Replacement Therapy
- Female
- Humans
- Middle Aged
- Osteoporosis, Postmenopausal
(prevention & control)
- Progesterone
(therapeutic use)
- Quality of Life
- Selective Estrogen Receptor Modulators
(therapeutic use)
|